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Background: Exome sequencing allows researchers to study the human genome in unprecedented detail. Among
the many types of variants detectable through exome sequencing, one of the most over looked types of mutation
is internal deletion of exons. Internal exon deletions are the absence of consecutive exons in a gene. Such deletions
have potentially significant biological meaning, and they are often too short to be considered copy number
variation. Therefore, to the need for efficient detection of such deletions using exome sequencing data exists.
Results: We present ExonDel, a tool specially designed to detect homozygous exon deletions efficiently. We tested
ExonDel on exome sequencing data generated from 16 breast cancer cell lines and identified both novel and
known IEDs. Subsequently, we verified our findings using RNAseq and PCR technologies. Further comparisons with
multiple sequencing-based CNV tools showed that ExonDel is capable of detecting unique IEDs not found by other
CNV tools.
Conclusions: ExonDel is an efficient way to screen for novel and known IEDs using exome sequencing data.
ExonDel and its source code can be downloaded freely at https://github.com/slzhao/ExonDel.Background
Exome sequencing is one of the most cost-efficient se-
quencing approaches for conducting genome research
on coding regions. The primary applications of exome
sequencing include detection of single nucleotide poly-
morphisms, somatic mutations, small and large struc-
tural variations, and copy number variations. There are
also some less obvious data mining opportunities through
exome sequencing data such as extraction of mitochon-
drial [1] and viral sequences [2]. Another less explored
genomic aberration that can be detected through exome
sequencing is internal exon deletions (IEDs). Not to con-
fuse with exon skipping, IEDs are the result of the deletion
of one or more consecutive exons in a gene where exon
skipping are artificial method used to encourage the cellu-
lar machinery to skip over an exon [3].
Functional IEDs were first described in murine T-cell
acute lymphoblastic leukemia (T-ALL), in which consti-
tutive ligand-independent activation of NOTCH1 oc-
curs from a deletion of exons 3-27, preserving the* Correspondence: yan.guo@vanderbilt.edu; Yu.Shyr@vanderbilt.edu
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unless otherwise stated.transcriptional binding domain in exons 28-34 [4]. A
similar IED was recently reported in a breast cancer cell
line, HCC1599 [5]. The number of deleted exons range
from a single exon to nearly the whole gene as in the
example of the HCC1599 cell line. These IEDs are often
too short to be considered copy number variation, thus
only the very large ones have a chance to be picked up
by sequencing-based CNV detectors. IEDs have bio-
logical importance in cancer, such as in the removal of
important regulatory mechanisms or protein-protein
interaction domains. Given the large amount of publi-
cally available exome sequencing data accumulated over
the last few years, a method that can efficiently detect
such deletions would benefit the medical research com-
munity greatly and provide means to rapidly identify
new IED candidates. Thus, we have designed ExonDel,
a tool aimed at detecting IEDs through exome sequen-
cing data. ExonDel is written in a combination of Perl
and R. ExonDel detects exon deletion at gene level ra-
ther than at global level, and it adjusts for GC content.Implementation
An IED can be homozygous or heterozygous. While
homozygous means that exon is deleted in both allele
and heterozygous means that the exon is deleted in one. This is an Open Access article distributed under the terms of the Creative
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ier and more accurately detectable than heterozygous
exon deletion. ExonDel is currently designed to detect
homozygous IEDs only. ExonDel differs from other
sequencing-based CNV tools by detecting exon deletion
on a per gene level instead of searching for large lengths
of depth variation across the whole genome. To achieve
this, ExonDel first computes callable genes based on dif-
ferent exome capture methodologies. There are three
major exome sequencing capture kits currently in broad
use: Illumina TruSeq, Agilent SureSelect, and Nimble-
Gen SeqCap EZ. The target regions for these three ex-
ome capture kits vary and range from 37.6 to 62.1
million base pairs. The capture kits available can enrich
the exome, and additional content includes exons plus 3’
and 5’ UTRs. The capture kits differ in their target re-
gions, bait length, bait density, and molecule used for
capture. To account for these differences, ExonDel com-
putes the callable genes first. A callable gene has to sat-
isfy the following two conditions: 1) all exons of this
gene must be covered by the exome capture kit, and 2)
each exon must have at least 90% of its base pairs cov-
ered by the exome capture kit. The first condition en-
sures that no false positive resulted from uncovered
exons in the capture kit. The second condition ensures
that no false positives resulted from partially covered
exons in the capture kit. ExonDel will only attempt to
detect exon deletions for the callable genes.Figure 1 Using data from all 16 samples, we show that depth drops fThe important inputs of ExonDel include a non-
optional Binary Alignment Map (BAM) [6] file, a non-
optional Browser Extensible Data (BED) file of the
capture kit, and an optional Gene Feature Format
(GTF) file. The BED file provides the exact capture re-
gions down to a single base-pair resolution. The GTF
file provides detailed information about the starts and
ends of exons. Both BED and GTF files are used to
compute callable genes: if GTF is not provided, ExonDel
will apply the latest gene annotation from RefSeq. Other
input parameters of ExonDel include a maximum window
size and a list of genes of interest. The maximum window
size parameter determines the max length IED that
ExonDel will search for. For example, if the maximum
window size is 7, ExonDel will search for IEDs with
length less than 7 exons. For the user-input list of genes
of interest, instead of searching though the entire ex-
ome, ExonDel will only search IEDs in the genes of
interest in order to save time.
The depth coverage of Illumina sequencing data can
be influenced by GC content [7]. Many sequencing-
based tools have taken the GC content’s effect on depth
into consideration. We also observed similar bias based
on analysis of exon depth (Figure 1). To minimize the effect
of GC-content bias on depth, we applied standardization of
depth by GC content followed by median correction, a
method described in [8]. The GC content was adjusted by
the following formula, ~r i ¼ rim mGC= where ri are the reador exons with low and high GC content.
Table 1 Exon deletion candidates identified by window
length, and comparison with other CNV tools using
breast cancer cell lines
Deletion window length 1 2 3 4 5 6 7 8 9
Exon Deletions1 13720 163 23 11 9 8 8 6 6
Verified in RNAseq2 1988 17 7 7 7 6 6 6 6
Found by CNV Tools3 6099 129 20 11 9 8 8 6 6
1Based on 16 samples.
2Based on 13 samples, 3 of the 16 samples did not have RNAseq data.
3Based on 16 samples.
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of all exons that have the same GC content as the ith exon.
In Yoon et al.’s original implementation, ri is the read
counts of the ith 100 bp window because copy number was
under consideration instead of exons.
ExonDel detects exon deletions by comparing each
exon’s depth against its parent gene’s median depth after
performing the depth adjustment by GC content de-
scribed previously. To ensure high specificity, reads with
poor mapping quality (MQ < 20 for BWA aligned BAMs)
are removed. If non BWA aligned BAMs are used (such
as BAMs from Bowtie 2 [9], where mapping quality defin-
ition is different), ExonDel will compute the average base
quality per read as BQr ¼
Xl
i
BQi where l is the length of
the read, and BQi is the base quality of ith nucleotide. All
reads with average BQr < 20 are removed.
IEDs can have lengths 1 to L-1, where L is the total
number of exons in a gene. Longer IEDs are more reli-
able than shorter IEDs because shorter IEDs, especially
for IEDs with length 1 are more likely to be falseFigure 2 Verification of NOTCH1 deletions found by ExonDel. The ma
large deletion in NOTCH1. RNAseq data further proves that such deletionspositives caused by sequencing artifacts. Potential IEDs
will be identified if the median depth of one or consecu-
tive exons are smaller than a certain user-adjustable per-
centage of the median depth within the gene. First we
define the median depth of the ith exon as DPei =median
(DP1to DPl), where l is the length of the exon. The list of
all median depths of all exons is denoted as DP all. An
exon is considered deleted if and only if the following con-
ditions are satisfied:
1. DPei < C1 % × DP all, C% ×DP all presents the
percentile of all exon depth, and C is a constant. By
default, C is 2. The user can manually adjust C to
change the sensitivity of ExonDel. Increasing C will
result more IEDs detected.
2. DPē > C2% Χ DPall, where ē denotes the exons
that do not satisfy condition 1. By default C is 10.
ExonDel performs the exon deletion detection at gene
level. Once it moves to the next gene, the condition is
reset. The number of exon deletions detected is inversely
proportional to this parameter (Table 1). When multiple
samples are loaded, ExonDel computes the summary
statistics of all samples.
To demonstrate the effectiveness of ExonDel, we used
two independent datasets. The first dataset contains ex-
ome sequencing data from 16 breast cancer cell lines.
The exomes were captured using Illumina’s TrueSeq
capture kit. Seventy five nucleotide paired-end sequen-
cing was performed using Illumina’s HiSeq 2000 platform at
Vanderbilt Genomic Core. RNAseq data RT-PCR were used
to validate the IEDs identified by ExonDel. Because ExonDelpping results of both exome sequencing and RNAseq data support the
can be carried through transcription to RNA.
Figure 3 Further validation of exon deletion on NOTCH1 was obtained using RT-PCR.
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neous (a mixture of tumor and normal tissues) compared to
cell line, we downloaded exome sequencing data of 10 breast
cancer tumor samples ("TCGA-A7-A0D9", "TCGA-BH-
A0B3", "TCGA-BH-A0B8", "TCGA-BH-A0BJ", "TCGA-BH-
A0BM", "TCGA-BH-A0C0", "TCA-BH-A0DK", "TCGA-BH-
A0DP", "TCGA-BH-A0E0", "TCGA-BH-A0H7") from The
Cancer Genome Atlas (TCGA). The corresponding RNAseq
data of the same 10 samples were also downloaded for
validation purpose.
Results
The 16 cell line datasets were processed in house using
standard sequencing processing pipeline. The complete
raw quality control results can be seen in Additional file 1:
Table S1. Alignment was done using BWA [10] against
the HG19 human genome reference. Statistics of align-
ments can be viewed in Additional file 2: Table S2. Using
ExonDel to screen for IED on the 16 cell line samples,
we identified both novel and known exon deletions
were observed. We were able to validate the previously
described deletion of exons 3 to 27 in NOTCH1 in cell
line HCC1599 and identify a similar deletion in cell line
MDA-MB-157. This previously unidentified IED of
exons 2 to 27 is similar to the deletion in HCC1599Figure 4 Comparison between ExonDel and other CNV calling tools. (
(B) The number of deletions detected using all tools at window size 1.and those described in murine T-ALL [4,5]. To verify
these findings we performed RNAseq on these cell
lines. Figure 2 depicts the sequencing depth coverage
using Integrative Genomics Viewer for both DNA exome
and RNAseq data for each of the cell lines. For compari-
son, we included a cell line without the NOTCH1 deletion
(HS578T) in Figure 2. Exons 3-27 and 2-27 are clearly de-
leted in HCC1599 and MDA-MB-157 respectively but re-
main intact in HS578T cells. These deletions are further
confirmed with RT-PCR (Figure 3).
In addition to the multi-exon deletion in NOTCH1,
many novel IED candidates were identified, some contain-
ing as few as a single exon (Table 1). IEDs with a single
exon are more likely to result from sequencing artifacts.
For comparative purposes, we screened our samples for
CNV using 6 sequencing data-based CNV callers: Exo-
meCNV [11], CNVnator [12], CoNIFER [13], Control-
FREEC [14], ExomeCopy [15] and cn.MOPS [16]. Even
after combining results from all six CNV tools, ExonDel
can still indentify many novel deletion candidates not
identified by other CNV tools (Table 1). Figure 4A dem-
onstrates the distribution of length of deletions detected
by each tool. Clearly, ExonDel can identify smaller dele-
tions while other CNV tools identified deletions with long
length. Figure 4B shows the number of deletions detectedA) The length distribution of the deletion detected by all tools;
Table 2 Exon deletion candidates identified by window
length, and comparison with other CNV tools using the
10 TCGA breast cancer tumor samples
Deletion window length 1 2 3 4 5 6 7 8 9
Exon deletions 13494 1734 524 230 94 38 20 13 7
Verified in RNAseq 4722 489 174 70 36 16 10 7 4
Found by CNV tools 2635 584 268 154 73 33 17 12 6
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ber of potential IEDs were identified by ExonDel on all 16
samples, given researcher a greater chance at identifying
the true biological relevant IDEs. The NOTCH1 deletion
we described was identified in 3 out of the 6 tested CNV
tools. The detailed results of the ExonDel and CNV com-
parison can be viewed in Additional file 3: Table S3.
We repeated the exon deletion analyses on the TCGA
tumor datasets. Because we do not have access to the actual
tumor sample, we could not perform RT-PCR validation.
RNAseq data was used for validation and comparisons with
the six CNV tools were conducted. Results of similar pat-
terns were identified. More IEDs can be detected with
smaller window size, and ExonDel was able to find more
IEDs at all windows sizes compared to the other six CNV
tools combined (Table 2). This result shows that ExonDel is
able to perform well on tumor samples.
Discussion
IEDs have functional implications in cancer genomics
and we have developed a tool, ExonDel, to screen for
novel IED candidates efficiently. Using a combination of
Perl and R, we provide a single package including all
source codes and instructions which is freely available
for download. While providing several important new
features, ExonDel also contains a few limitations. For ex-
ample, as the name indicates, ExonDel can only detect
exon deletion not amplification. The window size plays a
significant role in detection of IED. Large window size
ensures more accurate detection at the cost of missing
small IEDs. Small window size on the other hand, allows
to detection high number of IEDs at the cost of higher
false positive rate. Thus, we recommend running Exon-
Del at window size 1 to 7 in one setting, and scan for
potential biological meaningful IED candidates from the
results of larger window size to smaller window size.
ExonDel distinguish itself from other sequencing-
based CNV tools in two aspects. First, it performs dele-
tion detection at gene level and uses exon as unit. Other
sequencing-based CNV tools usually consider CNVs as
large deletion or duplication spanning large genomic re-
gions. It is common to see that CNV contains many genes
and the median length of CNV detected using sequencing-
based CNV tool is around 105 [17] and the average exon
less is less than 200 base pairs [18]. Thus, ExonDel isvery efficient, and one exome can be screened in about
15 minutes. ExonDel also allows the user to define the
deletion window size and can be configured to run
multiple BAM files in parallel.
In theory, ExonDel is designed to work with both
tumor and cell line samples. Tumor samples differ from
cell lines samples because they are usually a mixture of
tumor and normal tissues. Thus, tumor sample contains
noises which can mask the true variant signal. This is a
challenge all variant callers have to face. If the tumor
purity is low, a deleted exon might have reads aligned to
it due to the presents of normal tissue. In such cases,
ExonDel would not able to identify such IEDs. As shown
in our TCGA tumor dataset results (Table 2), ExonDel
was able to identify many potential IEDs, and a signifi-
cant portion of them were verifiable by RNAseq and
other CNV tools. This indicates that either the purities
of these tumors were good, or many true IEDs were not
affected by tumor heterogeneity. A portion of IEDs
might still be affected by tumor heterogeneity, and these
IEDs were not detectable by ExonDel.
Conclusion
Given the large volume of exome sequencing data publi-
cally available in repositories such as TCGA, the 1000
Genomes Project, NHLBI Exome Sequencing Project,
and The Sequence Reads Archive, ExonDel provides re-
searchers with a powerful tool to mine for internal dele-
tions that may contain novel biological findings.
Availability and requirements
Project name: e.g. ExonDel project
Project home page: e.g. https://github.com/slzhao/ExonDel
Operating system(s): Linux
Programming language: Perl, R
License: GPL v2
Any restrictions to use by non-academics: No
Additional files
Additional file 1: Raw data quality control matrix.
Additional file 2: Alignment quality control matrix.
Additional file 3: Comparison between ExonDel and six other CNV
tools.
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